Drug manufacturers in the Indian states of Haryana and Uttar Pradesh are more likely to produce substandard or falsified drugs than those in more regulated Indian states, an expert says. . . .
To read the remainder of this article, click here (note you must be a member PharmaSupplyChain.com)
No comments:
Post a Comment